Finally, in multiple CRC cell types, including PD-CRC, HCT116, and LoVo cells, CCND2 was preferentially expressed in CD44v6+ cells rather than in CD44v6- cells (Fig. 5g). This evidence concerns the gene CCND2 and colorectal carcinoma.